Transplant Patients' Isolation and Social Distancing Because of COVID-19: Analysis of the Resilient Capacities of the Transplant in the Management of the Coronavirus Emergency.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 18 05 2020
revised: 23 05 2020
accepted: 26 05 2020
pubmed: 20 6 2020
medline: 11 11 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

One of the peculiar aspects of the transplant patient's life is that, in the post-surgery phase, the patient lives in an "isolation" condition, having to pay particular attention to the living environment and preferring a limited social life given that the immunosuppressive treatment entails immunodepression in the patient. With coronavirus disease 2019 (COVID)-19, as in a post-surgery situation, social isolation is being implemented. The study started on March 17, 2020, and ended on April 24, 2020. Consulting/phone interviews were made. The phone questionnaire, submitted to 71 patients, consisted of a set of 15 questions that investigated structure and psychological resistance. Eight patients have been monitored exclusively for the psychological aspect through a more articulate supporting path. In essence, from the overall analysis of the data derived from the study of the positioning of patients based on the stage of renal function, the bands related to the development of psychopathological aspects, and the use of positive personal resources, it emerges that patients in stage V kidney failure are in the first bracket as regards the development of psychopathological aspects (absence of these experiences) and in the third bracket as regards the good use of positive resources to deal with isolation. Therefore, it can be deduced that, although with data that can be expanded, a serious or medium-serious situation from an organic point of view in this socio-health emergency situation is well addressed by the transplanted patient. Transplant patients have faced the measure of social distancing adequately and in adherence to the treatment thanks to the phone assistance of all the medical-surgical and psychological team.

Sections du résumé

BACKGROUND BACKGROUND
One of the peculiar aspects of the transplant patient's life is that, in the post-surgery phase, the patient lives in an "isolation" condition, having to pay particular attention to the living environment and preferring a limited social life given that the immunosuppressive treatment entails immunodepression in the patient. With coronavirus disease 2019 (COVID)-19, as in a post-surgery situation, social isolation is being implemented.
MATERIALS AND METHODS METHODS
The study started on March 17, 2020, and ended on April 24, 2020. Consulting/phone interviews were made. The phone questionnaire, submitted to 71 patients, consisted of a set of 15 questions that investigated structure and psychological resistance. Eight patients have been monitored exclusively for the psychological aspect through a more articulate supporting path.
RESULTS RESULTS
In essence, from the overall analysis of the data derived from the study of the positioning of patients based on the stage of renal function, the bands related to the development of psychopathological aspects, and the use of positive personal resources, it emerges that patients in stage V kidney failure are in the first bracket as regards the development of psychopathological aspects (absence of these experiences) and in the third bracket as regards the good use of positive resources to deal with isolation. Therefore, it can be deduced that, although with data that can be expanded, a serious or medium-serious situation from an organic point of view in this socio-health emergency situation is well addressed by the transplanted patient.
CONCLUSION CONCLUSIONS
Transplant patients have faced the measure of social distancing adequately and in adherence to the treatment thanks to the phone assistance of all the medical-surgical and psychological team.

Identifiants

pubmed: 32553507
pii: S0041-1345(20)32570-7
doi: 10.1016/j.transproceed.2020.05.031
pmc: PMC7260500
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2626-2630

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nephrol Dial Transplant. 2001 Jul;16(7):1395-401
pubmed: 11427631
Nephrol Dial Transplant. 2019 Jun 1;34(6):1045-1055
pubmed: 30544241
Transplant Proc. 1997 Feb-Mar;29(1-2):1569-70
pubmed: 9123428
Public Health Nurs. 2005 Sep-Oct;22(5):398-406
pubmed: 16229732
Epidemiol Health. 2016 Nov 5;38:e2016048
pubmed: 28196409
Transplant Proc. 2001 Nov-Dec;33(7-8):3697
pubmed: 11750575
Nephrol Dial Transplant. 2015 May;30(5):752-61
pubmed: 24950938
Qual Life Res. 1992 Apr;1(2):119-28
pubmed: 1301119
Clin Transplant. 2001 Oct;15(5):330-6
pubmed: 11678959
Curr Transplant Rep. 2018 Jun;5(2):174-188
pubmed: 30416933
Int J Artif Organs. 1998 Nov;21(11):741-7
pubmed: 9894753
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Transplant Rev (Orlando). 2020 Jan;34(1):100511
pubmed: 31627978
Gen Hosp Psychiatry. 2011 Jan-Feb;33(1):1-7
pubmed: 21353121
Health Psychol. 2018 Sep;37(9):808-813
pubmed: 30138019
Clin Infect Dis. 2004 Apr 1;38(7):925-31
pubmed: 15034821
Transplantation. 1999 Nov 15;68(9):1331-5
pubmed: 10573072
Gen Hosp Psychiatry. 1996 Nov;18(6 Suppl):62S-69S
pubmed: 8937924
Epidemiol Infect. 2008 Jul;136(7):997-1007
pubmed: 17662167
Kidney Int. 1996 Mar;49(3):833-8
pubmed: 8648927
Transplantation. 2006 Jul 15;82(1):80-5
pubmed: 16861945
Transplant Proc. 2002 Sep;34(6):2192-3
pubmed: 12270360

Auteurs

Diana Lupi (D)

Centro Regionale Trapianti-Regione Abruzzo-Regione Molise, L'Aquila, Italy. Electronic address: dianalupi@gmail.com.

Barbara Binda (B)

U.O.C. Chirurgia Generale e dei Trapianti d'Organo, L'Aquila, Italy.

Filippo Montali (F)

Università degli Studi dell'Aquila, Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, L'Aquila, Italy.

Andrea Natili (A)

U.O.C. Chirurgia Generale e dei Trapianti d'Organo, L'Aquila, Italy.

Laura Lancione (L)

U.O.C. Chirurgia Generale e dei Trapianti d'Organo, L'Aquila, Italy.

Davide Chiappori (D)

U.O.C. Chirurgia Generale e dei Trapianti d'Organo, L'Aquila, Italy.

Ida Parzanese (I)

Centro Regionale Trapianti-Regione Abruzzo-Regione Molise, L'Aquila, Italy.

Daniela Maccarone (D)

Centro Regionale Trapianti-Regione Abruzzo-Regione Molise, L'Aquila, Italy.

Francesco Pisani (F)

U.O.C. Chirurgia Generale e dei Trapianti d'Organo, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH